These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35271463)

  • 1. Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis.
    Cao C; Gan X; Hu X; Su Y; Zhang Y; Peng X
    Aging (Albany NY); 2022 Mar; 14(5):2062-2080. PubMed ID: 35271463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants.
    Wu Q; Luo S; Xie X
    BMC Cancer; 2022 Mar; 22(1):241. PubMed ID: 35246063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.
    Park R; Lee SA; Kim SY; de Melo AC; Kasi A
    Acta Oncol; 2021 Jan; 60(1):13-19. PubMed ID: 33131376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.
    Yekedüz E; Utkan G; Ürün Y
    Eur J Cancer; 2020 Dec; 141():92-104. PubMed ID: 33130550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients.
    Di Felice G; Visci G; Teglia F; Angelini M; Boffetta P
    Elife; 2022 Feb; 11():. PubMed ID: 35171096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
    Wang B; Huang Y
    Oncoimmunology; 2020 Sep; 9(1):1824646. PubMed ID: 33294299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
    van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
    BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
    Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
    Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies.
    Desai A; Gupta R; Advani S; Ouellette L; Kuderer NM; Lyman GH; Li A
    Cancer; 2021 May; 127(9):1459-1468. PubMed ID: 33378122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?].
    Lanthier L; Carignan A; Plourde MÉ; Cauchon M
    Rev Med Interne; 2021 Mar; 42(3):227-228. PubMed ID: 33612319
    [No Abstract]   [Full Text] [Related]  

  • 12. A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus.
    Venkatesulu BP; Chandrasekar VT; Girdhar P; Advani P; Sharma A; Elumalai T; Hsieh CE; Elghazawy HI; Verma V; Krishnan S
    JNCI Cancer Spectr; 2021 Apr; 5(2):pkaa102. PubMed ID: 33875976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.
    Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis.
    Singh A; Hussain S; Antony B
    Diabetes Metab Syndr; 2021; 15(3):813-822. PubMed ID: 33862417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
    Pala L; Conforti F; Saponara M; De Pas T; Giugliano F; Omodeo Salè E; Jemos C; Rubatto M; Agostini A; Quaglino P; Fava P; Fierro MT; Queirolo P
    Semin Oncol; 2020 Oct; 47(5):302-304. PubMed ID: 32883537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
    Lin Z; Chen J; Han S
    Expert Rev Anticancer Ther; 2021 Sep; 21(9):1055-1066. PubMed ID: 33970745
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of asymptomatic COVID-19 infection in cancer patients. A cross-sectional study at a tertiary cancer center in New York City.
    Ibrahim M; Natarajan V; Murthy P; Meghal T; Xu Y; Wiesel O
    Cancer Treat Res Commun; 2021; 27():100346. PubMed ID: 33756172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study.
    Murk W; Gierada M; Fralick M; Weckstein A; Klesh R; Rassen JA
    CMAJ; 2021 Jan; 193(1):E10-E18. PubMed ID: 33293424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.
    You JH; Lee SA; Chun SY; Song SO; Lee BW; Kim DJ; Boyko EJ
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):901-908. PubMed ID: 33297603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.